Consumption rates among Americans of marijuana and hallucinogenic substances are at historic levels. Investors are taking notice. Read More

New research shows that psilocybin can be more effective and less expensive than conventional drug therapies for severe depression. Read More

The German government approved legislation this week that would allow adults to buy and possess recreational cannabis. The stakes are huge. Read More

It may be the dog days of August, but legal, regulatory, and political trends that affect the worldwide cannabis sector continue apace. Read More

Cannabidiol (CBD) is evolving into a mainstream consumer product. CBD won’t make you high, but it can make you rich. Read More

Psychedelics such as magic mushrooms are poised to play key roles in medicine and psychiatry. There’s big money in those fungi. Read More

A new study shows that states with legalized adult-use marijuana have witnessed a dramatic drop in mental health treatment admissions. Read More

Congressional lawmakers this week are pushing an amendment to an appropriations bill that would facilitate research into psychedelics. Read More

Republicans are pushing a bill in Congress to lift federal restrictions on marijuana, further proof that the "green rush" is alive and well. Read More

The campaign to lift restrictions on “magic mushrooms" has been cleared to collect signatures for a 2024 ballot Initiative in California. Read More